Purchase Order 36C24225P1498

This federal contract award was issued by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The contract is a delivery order under Takeda's General Services Administration (GSA) Pharmaceuticals and Drugs Schedule contract, with a ceiling value of $55,335.60 and a completion date of June 28, 2024. The contract is for the supply of TAKHZYRO, a specialty pharmaceutical product...

This is a firm fixed-price delivery order awarded to Takeda Pharmaceuticals America Inc. by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). The contract is for the delivery of TAKHZYRO 150 MG, a specialized pharmaceutical product, with a ceiling value of $36,984.28 and a period of performance through August 5, 2025. The contract is not set aside and is awarded under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule...

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The $33,974.90 contract is for the supply of TAKHZYRO, an emergency medication, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule. The contract is not set aside and represents one of multiple federal awards held by Takeda, demonstrating the...

The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $36,101.68 firm fixed price delivery order for two packages of TAKHZYRO 150MG/ML prefilled syringes. Takeda Pharmaceuticals America Inc. will deliver the packages of the hereditary angioedema preventative medication to a location in Lexington, Massachusetts by November 1, 2023 to support VHA programs. The award was issued against Takeda Pharmaceutical Company Limited's...

This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awards Takeda Pharmaceuticals America Inc. a $36,890.40 firm fixed price contract to supply TAKHZYRO 150MG/ML SYRINGE 2ML PER SYRINGE with a quantity of 2. The contract is issued against Takeda Pharmaceuticals America Inc.'s existing Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance taking place in Lexington, Massachusetts. No...

This firm fixed price delivery order for $36,890.40 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 to Takeda Pharmaceuticals America Inc. against the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for two 150 mg/ml, 2ml injectable syringes of TAKHZRYO to treat hereditary angioedema. Performance will take place in Lexington, Massachusetts by February 6, 2024. No set-aside was applied given the...

This federal contract award, valued at $32,448.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a completion date of July 9, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans...

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The $36,890.40 order is for the specialty pharmaceutical product TAKHZYRO 150MG ML SYRINGE 2ML PER SYRINGE, which is used to treat hereditary angioedema. The delivery order has an April 2024 completion date and will support patient care programs across the VA's Veterans...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Takeda Pharmaceuticals America Inc. a $36,890.40 firm fixed price delivery order for TAKHZYRO under the company's Pharmaceuticals and Drugs General Services Administration schedule contract. TAKHZYRO will be delivered to facilities in Lexington, Massachusetts by June 7, 2024 to support treatment of hereditary angioedema. No set-aside was applied given the specialized nature of the...

This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical drug Takhzyro, a treatment for hereditary angioedema. The $32,448.80 firm fixed price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...